Startups
Developing Innovative Therapeutics for Ocular Diseases Global leading candidate in Phase 2b for the treatment of adenoviral conjunctivitis. Research & Development Enhancing Lives Through Better Vision Okogen, founded in 2015, is a clinical stage ophthalmic specialty biotechnology company. We are exclusively focused on developing the leading treatment of adenoviral conjunctivitis. With acute conjunctivitis representing 1% […]
Overview
Location
United States, California, San Diego
Employees
1-10
Founded date
2015
FAQ about Okogen
When was Okogen founded?
Okogen was founded in 2015.
Is Okogen still active?
Yes, Okogen is active.